摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-bromo-3-methyl-4-pyrimidone | 14248-02-3

中文名称
——
中文别名
——
英文名称
5-bromo-3-methyl-4-pyrimidone
英文别名
5-Brom-1-methyl-6-oxo-1,6-dihydro-pyrimidin;5-Brom-3,4-dihydro-3-methyl-pyrimidon-(4);5-Brom-1,6-dihydro-1-methyl-6-oxo-pyrimidin;5-Brom-3-methyl-4-pyrimidinon;5-bromo-3-methyl-3H-pyrimidin-4-one;5-bromo-3-methylpyrimidin-4(3H)-one;5-bromo-3-methylpyrimidin-4-one
5-bromo-3-methyl-4-pyrimidone化学式
CAS
14248-02-3
化学式
C5H5BrN2O
mdl
MFCD00834961
分子量
189.011
InChiKey
XESUZSMJHLRVDK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    32.7
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-bromo-3-methyl-4-pyrimidone盐酸(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloridepotassium carbonate三乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 1,4-二氧六环甲醇二氯甲烷 为溶剂, 反应 9.0h, 生成 1-isopropyl-N-(1-(4-(1-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)phenyl)cyclopropyl)-1H-pyrazolo[3,4-d]pyrimidine-6-carboxamide
    参考文献:
    名称:
    [EN] PYRIMIDINONE COMPOUNDS AND USES THEREOF
    [FR] COMPOSÉS DE PYRIMIDINONE ET LEURS UTILISATIONS
    摘要:
    本发明涉及嘧啶酮化合物及其用途。具体而言,本发明涉及公式(I)的嘧啶酮化合物,以及制备方法、制药组合物和用途,其中变量如描述中所定义。
    公开号:
    WO2022037585A1
  • 作为产物:
    描述:
    3-甲基嘧啶-4-酮 在 bromination 作用下, 生成 5-bromo-3-methyl-4-pyrimidone
    参考文献:
    名称:
    Jones, Gurnos; Tonkinson, Daryl J.; Hayes, Peter C., Journal of the Chemical Society. Perkin transactions I, 1983, # 11, p. 2645 - 2648
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • BENZENE DERIVATIVE OR SALT THEREOF
    申请人:Hirayama Fukushi
    公开号:US20090054352A1
    公开(公告)日:2009-02-26
    Problem: To provide compounds which have an anticoagulation effect based on their ability to inhibit the activated blood coagulation factor X and are useful as coagulation inhibitors or agents for prevention or treatment for diseases caused by thrombi or emboli. Means for Solution: Benzene derivatives or their salts having a characteristic chemical structure with a phenol ring and a benzene ring bonding to each other via an amide bond, in which the phenol ring further bonds to a benzene ring or a heteroaryl ring via an amide bond. They have an excellent effect of inhibiting the activated blood coagulation factor X, and especially have an excellent oral activity.
    问题:提供具有抗凝作用的化合物,其基于其抑制活化的血液凝血因子X的能力,并且可用作凝血抑制剂或用于预防或治疗由血栓或栓子引起的疾病的药物。 解决方法:苯衍生物或其盐具有特征化学结构,其中苯酚环和苯环通过酰胺键相互结合,其中苯酚环通过酰胺键进一步结合到苯环或杂环环上。它们具有出色的抑制活化的血液凝血因子X的效果,尤其是具有出色的口服活性。
  • Benzene derivative or salt thereof
    申请人:Astellas Pharma Inc.
    公开号:US08022208B2
    公开(公告)日:2011-09-20
    Problem: To provide compounds which have an anticoagulation effect based on their ability to inhibit the activated blood coagulation factor X and are useful as coagulation inhibitors or agents for prevention or treatment for diseases caused by thrombi or emboli. Means for Solution: Benzene derivatives or their salts having a characteristic chemical structure with a phenol ring and a benzene ring bonding to each other via an amide bond, in which the phenol ring further bonds to a benzene ring or a heteroaryl ring via an amide bond. They have an excellent effect of inhibiting the activated blood coagulation factor X, and especially have an excellent oral activity.
    问题:提供具有抗凝作用的化合物,基于它们抑制活化的血液凝血因子X的能力,并可用作凝血抑制剂或用于预防或治疗由血栓或栓塞引起的疾病的药剂。 解决方法:苯衍生物或其盐具有特征性化学结构,其中苯环和苯环通过酰胺键连接,苯环进一步通过酰胺键连接到苯环或杂环环上。它们具有抑制活化的血液凝血因子X的优异效果,尤其具有优异的口服活性。
  • EP1947086
    申请人:——
    公开号:——
    公开(公告)日:——
  • [EN] STAT MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE STAT ET LEURS UTILISATIONS
    申请人:[en]RECLUDIX PHARMA, INC.
    公开号:WO2023133336A1
    公开(公告)日:2023-07-13
    Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with STAT3 and/or STAT6.
  • Jones, Gurnos; Tonkinson, Daryl J.; Hayes, Peter C., Journal of the Chemical Society. Perkin transactions I, 1983, # 11, p. 2645 - 2648
    作者:Jones, Gurnos、Tonkinson, Daryl J.、Hayes, Peter C.
    DOI:——
    日期:——
查看更多